Serum Steroid Profiling in the Diagnosis of Adrenocortical Carcinoma: A Prospective Cohort Study
We showed that measurements of 11-deoxycortisol, 17OH-progesterone, and 17OH-pregnenolone could be valuable in diagnosing ACC. After appropriate validation, serum steroid score could be integrated in clinical practice.
Authors
- Kai Yu (ORCID: https://orcid.org/0000-0001-8794-0318)
- Irina Bancos (ORCID: https://orcid.org/0000-0001-9332-2524)
- Travis J. McKenzie (ORCID: https://orcid.org/0000-0002-1343-6941)
- Shobana Athimulam (ORCID: https://orcid.org/0000-0003-1693-3553)
- Jasmine Saini (ORCID: https://orcid.org/0000-0001-7156-6229)
- Ravinder Jeet Kaur (ORCID: https://orcid.org/0000-0001-6445-2776)
- Ravinder J. Singh (ORCID: https://orcid.org/0000-0003-4538-6544)
- Qingping Xue (ORCID: https://orcid.org/0000-0001-6166-2313)
- Stefan K. Grebe
Institutions
- Mayo Clinic (US)
- Henry Ford Health System (US)
- Chengdu Medical College (CN)
- Sichuan University (CN)
- WinnMed (US)
- Henry Ford Hospital (US)
- Mayo Clinic in Arizona (US)
- Public Health Clinical Center of Chengdu (CN)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1210/clinem/dgae604
- Citations
- 9
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 5.15
Funders
- National Institutes of Health
- National Institute on Aging
- National Institute of Diabetes and Digestive and Kidney Diseases